1. Home
  2. CNA vs NBIX Comparison

CNA vs NBIX Comparison

Compare CNA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNA Financial Corporation

CNA

CNA Financial Corporation

HOLD

Current Price

$52.11

Market Cap

14.2B

Sector

Finance

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$164.11

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNA
NBIX
Founded
1853
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
13.2B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
CNA
NBIX
Price
$52.11
$164.11
Analyst Decision
Strong Buy
Analyst Count
0
22
Target Price
N/A
$180.91
AVG Volume (30 Days)
481.6K
1.3M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
8.20%
N/A
EPS Growth
33.24
41.95
EPS
1.95
3.30
Revenue
$14,989,000,000.00
$161,626,000.00
Revenue This Year
N/A
$24.73
Revenue Next Year
N/A
$13.14
P/E Ratio
$26.98
$48.43
Revenue Growth
5.04
977.51
52 Week Low
$41.53
$122.14
52 Week High
$55.71
$186.12

Technical Indicators

Market Signals
Indicator
CNA
NBIX
Relative Strength Index (RSI) 54.79 37.84
Support Level $44.63 $153.96
Resistance Level $52.86 $160.08
Average True Range (ATR) 1.30 6.51
MACD -0.34 -2.47
Stochastic Oscillator 29.37 4.87

Price Performance

Historical Comparison
CNA
NBIX

About CNA CNA Financial Corporation

CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: